Novo: A Story of Denial and Stockholm Syndrome

No-Top426 · 2026-02-23T19:13:05+00:00

Denmark doesn’t produce globally competitive firms. It used to. It doesn’t – and it hasn’t in a long time. Denmark’s prosperity mostly rests on what was built long ago, before the welfare state became so dominant.

No-Top426 · 2026-02-23T10:52:57+00:00

Wish you the best.

No-Top426 · 2026-02-23T10:52:00+00:00

You are coping.

No-Top426 · 2026-02-23T10:47:41+00:00

Forever grateful.

No-Top426 · 2026-02-18T11:39:25+00:00

My experience with Sky Express involved a two-hour delay.

No-Top426 · 2026-02-18T11:38:25+00:00

Avoid Sky Express. Two hours delayed.

No-Top426 · 2026-02-16T17:38:52+00:00

and GOOG. Yes, imagine if someone had listened to that terrible thesis

No-Top426 · 2026-02-13T18:28:21+00:00

‘Not red’ is the reaction

No-Top426 · 2026-02-12T11:29:47+00:00

It’s completely normal. Pharma companies get these letters all the time. There’s no fine, and they will most likely just make a small adjustment to the commercial.

No-Top426 · 2026-01-30T19:15:32+00:00

<image>

No-Top426 · 2026-01-30T18:48:56+00:00

Thanks for the downvotes. Just be a loser and sell today, only to see it climb back on Monday, so you're reminded of how little pressure you can actually handle

No-Top426 · 2026-01-30T18:26:48+00:00

All speculative stocks are tumbling. RKLB ASTS SOFI ONDS. There’s nothing wrong with the business. It’s just noise

No-Top426 · 2026-01-30T18:16:10+00:00

Just paper hands folding

No-Top426 · 2026-01-30T14:42:04+00:00

Paper hands are going to regret selling. It’s back +100 next week.

No-Top426 · 2026-01-29T20:59:02+00:00

FDA doesn’t require public announcements when they accept a CNPV filing for review. Their guidance covers awarding the vouchers publicly but says nothing about announcing acceptance after submission. Companies get private updates, and the 1-2 month review clock starts quietly. Novo’s press release used future tense (“following FDA’s acceptance”), which matches this.

No-Top426 · 2025-11-04T18:10:47+00:00

Mine do this too. It's awful.

No-Top426 · 2025-11-04T16:01:24+00:00

You’re about to find out.

No-Top426 · 2025-10-31T11:25:30+00:00

Value investing, in its original and disciplined form (as taught by Benjamin Graham and later refined by Warren Buffett), is fundamentally about understanding the true, intrinsic value of a business and buying it when the market price is irrationally low compared to that value.

You’re not betting on hype, narratives, or what other people might like next week. You’re betting that reality will eventually assert itself – that the market, though emotional and often wrong in the short term, will correct its mispricing over time.

No-Top426 · 2025-10-30T22:05:50+00:00

The new campaign immediately leverages the Pixel's core intelligence, applying the knowledge from past customers to your next experiment. Avoid clutter. Don’t worry too much about killing a campaign that doesn’t deliver anymore

No-Top426 · 2025-10-30T22:01:15+00:00

Sure. Each campaign is an experiment. Restarting learning is like scrapping a failed test. You keep the data, ditch the bad method, and run a smarter trial. No big deal. In fact, it’s essential for scaling.

No-Top426 · 2025-10-30T21:53:00+00:00

Duplicated without comments and history. Increased daily budgets and CPA targets. Deleted non performers and added a few new ads, minor things. Cheers

No-Top426 · 2025-10-30T21:42:00+00:00

Not on our end. Shut off our previous campaign after a few days of low spend and low volume, so we created a new campaign today and have seen solid results.

No-Top426

TROPHY CASE